Google Alert - lose weight

	lose weight As-it-happens update ⋅ October 1, 2026
	NEWS
	EASD 2026: EloraTZP Bests Tirzepatide on Weight Loss, A1C in Type 2 Diabetes | HCPLive HCPLive Across EloraTZP dose tiers, 48-week mean weight loss ranged 13.2%–23.3% with A1C reductions 2.2%–2.9% from a baseline A1C of 8.1%. Flag as irrelevant
	How medical weight loss can fit into a person's long-term health - KRCR KRCR Nutrition and physical activity remain important parts of weight loss, but medical understanding of obesity has evolved over time to consider ... Flag as irrelevant
	Eli Lilly Says Foundayo Drug Helped Patients Lose Weight in Phase 3 Trial - MarketWatch MarketWatch Eli Lilly's potential new weight-loss drug Foundayo had positive results in a Phase 3 trial. Foundayo, which is being studied as a treatment for ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback